It is noteworthy that serum and CSF Spp1 levels were shown to be elevated in other neurodegenerative disorders, such as Alzheimer disease13, 15 and Parkinson disease,29 suggesting that Spp1 may not function as a disease‐specific diagnostic biomarker for ALS. The gene discussed is SPP1; the disease is Parkinson disease.